Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Syncom Healthcare Ltd Stock Analysis

Small Cap
Evaluated by 350 users | BSE: 533157 | NSE: SYNCOM |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 7.61%4.75%0.54%1.37%-0.88%-0.35%-0.68%-23.74%-43.44%-38.19%-67.28%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 66.975.685.894.163.661.962.952.841.564.1202
Y-o-Y Gr. Rt.-13.1%13.6%9.7%-32.4%-2.8%1.7%-16%-21.4%54.4%-68.9%-
Adjusted EPS (Rs.) 2.111.38-0.170.06-1.18-0.97-0.91-9.25-7.52-2.86-2.93-1.13
Y-o-Y Gr. Rt.--34.6%-112.3%NA-2066.7%NANANANANANA-
Book Value per Share (Rs.) 43.6142.9345.7943.0941.4240.5539.7919.022.62-0.23-3.1-4.33
Adjusted Net Profit 3.75.5-0.70.2-4.7-3.9-3.6-37-30.1-11.4-11.7-5
Net Op. Cash Flow (Rs. Cr.) -18-8.3-1011044.711.40.23.95.71.3-0.1-
Debt to Cash Flow from Ops -1.36-2.13-0.220.37.932.47152.346.664.3818.12-271.28-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Syncom Healthcare Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -13.8%-20.2%-27.7%-68.9%
Adjusted EPS -208.7%NANANA
Book Value per Share -174.7-159.8-154.60
Share Price -10.7% -9.9% 9.1% 98.1%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 7.524.45-0.370.13-2.78-2.35-2.24-31.34-69.52-239.16176.130.42
Operating Profit Margin (%) 13.477.262.113.99-4.582.541.01-4.27-12.42-2.91-9.15-164.9
Net Profit Margin (%) 5.527.3-0.770.25-7.44-6.3-5.77-70.05-72.44-17.84-58.73-243.01
Debt to Equity 0.320.10.120.180.220.170.20.342.38-26.49-1.91-
Working Capital Days 338403632667685543459480455223363-
Cash Conversion Cycle 2032081871632272102031881066-63-
Loading price chart...
Entity Percentage Holding
Promoters 0.13%
Non-Institutions 99.87%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Syncom Healthcare Ltd's earnings have grown by 0%, whereas share price has declined -9.9% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.

Syncom Healthcare Ltd share price has declined -10.7% annually (CAGR) over the past ten years.

Data is not available for this company.

The Company was originally incorporated as Syncom Healthcare Limited on July 29, 2002 by Registrar of Companies, Maharashtra, Mumbai. The Certificate for Commencement of business was granted on August 2, 2002. The company has been promoted by Ajay Bankda & Jyoti Bankda. The company was formed for manufacturing, marketing & trading of pharmaceuticals formulations under its own brands in Ethical, OTC, Generic and Herbal market segment.

Initially it started its journey with the

The Company was originally incorporated as Syncom Healthcare Limited on July 29, 2002 by Registrar of Companies, Maharashtra, Mumbai. The Certificate for Commencement of business was granted on August 2, 2002. The company has been promoted by Ajay Bankda & Jyoti Bankda. The company was formed for manufacturing, marketing & trading of pharmaceuticals formulations under its own brands in Ethical, OTC, Generic and Herbal market segment.

Initially it started its journey with the marketing of the pharmaceuticals products manufactured by others under its own brand and in year 2006, the company set up a State of Art manufacturing unit at Dehradun in Uttarakhand. The unit was commissioned in November, 2006. During the year ended March 31, 2007, the net profit before tax & extra-ordinary items, of the Company increased to Rs.331.38 lakh from Rs.32.20 lakh during the year ended March 31, 2006 due to commencement of manufacturing of the various products in its own manufacturing unit and marketing through a strong distribution network.

SHL started as a marketing Company, which was outsourcing its requirement of finished products (Under Its Own Brand And Drug License) from other formulation manufacturing units based in and around Indore. Presently also SHL is outsourcing some of its requirement of finished products. With these companies, Syncom has a purchase and sale arrangement where the supplier unit is manufacturing SHL’s products on SHL’s specification and under SHL’s quality control under which SHL controls the quality of raw material, their sourcing by the supplier as well as production in the units of these suppliers. The manufactured goods, manufactured for SHL are sold to SHL on pre-decided order prices for each formulation product so manufactured.

To cater the diversified and increased demand the Company planned to set up its own pharmaceutical manufacturing facilities. Accordingly, the company set up a manufacturing facility at Dehradun in the state of Uttrakhand, which is a Tax free & duty free Zone. The Company set up its Plant at Dehradun and it started the commercial production in November, 2006. Presently Company is Manufacturing, Marketing and Distributing its Pharmaceutical Formulations under own Brands of Ethical, OTC, Generic and Herbal market segment.

Product range of the company:

Syncom has presence in Pharmaceuticals Formulations which can be categorized in 4 broad categories i.e. Generic, OTC, Ethical and Herbal. The company manufactures a range of products such as Ethical drugs, Generic drugs, over the counter drugs (OTC) and Herbal formulations in various dosage forms and markets them under the trade mark ‘Syncom’ which is a registered trademark in the name of Syncom Healthcare Limited. The company also undertakes contract manufacturing for large variety of pharmaceutical formulations for a number of other pharmaceutical companies of national and international repute such as Lupin Limited, Nicholas Piramal India Ltd, Galpha Laboratories Limited, Percos India Pvt. Ltd etc. (under their own brands) located in India.

The company manufactures various dosage forms, which include tablets, capsules, eye/ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and minimetro cities, which enable it to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the Company’s business has been categorized as Branded Generic Division, Over the Counter (OTC), Ethical division and Contract Manufacturing Division.

The Company is producing more than 130 products in Generic segment which includes CTZ, Profeed, Nimjet, Divoron, Gentijet, Ciprojet, etc.

Apart form Generic, the Company has developed presence in OTC Segment. The Company is producing more than 40 products in this segment which include Fastac, Q-coril, Triple action, Pandrop, Syncom Gripe Water, etc. Having built-up a presence in Generic & OTC segment and as a measure to expand and grow, the Company has also entered into Ethical segment. Syncom has developed more than 20 products in this segment which includes Fresca, Flusa, Nutone, Busera, etc.

Syncom is also having presence in Herbal segment with around 25 products which includes Patton, Attom, Narisudha, Salony Cream, etc.

Milestones:

  • 2002 - Incorporation of Syncom Healthcare Limited
  • 2002 - Syncom Healthcare Limited started marketing operations
  • 2005 - Commenced setting up of manufacturing facility at Selaqui, Dehradun
  • 2006 - Start of commercial production at Dehradun Industrial Unit for its own marketing
  • 2007 - Entered into agreement for Contract manufacturing with Lupin Limited, Galpha Laboratories, Nicholas Piramal, etc. Pharmaceutical Companies for manufacturing its various range of products.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback